HOME >> BIOLOGY >> NEWS
Male susceptibility to disease may play role in evolution of insect societies

A pair of scientists has proposed a new model for behavioral development among social insects, suggesting that a higher male susceptibility to disease has helped shape the evolution of the insects' behavior.

What might be called the "sick-male" theory has been proposed by animal behaviorists Sean O'Donnell of the University of Washington and Samuel Beshers of the University of Illinois at Urbana-Champaign, and appears in the current issue of Proceedings Biological Sciences, published by the Royal Society of London.

Among behaviors possibly affected are the division of labor between males and females and the relative social isolation experienced by males in many social insect colonies.

The researchers looked at Hymenoptera, an order of insects, including bees, ants and wasps, some of which have highly complicated societies and an unusual genetic makeup. These insects are called haplodiploids because males and females have a different number of sets of chromosomes. The females, like most animals, including humans, are diploid and have two sets of chromosomes, one from each parent. Hymenopteran males, however, hatch from unfertilized eggs and are haploids with just one set of chromosomes.

"Disease and infections are a very powerful and ongoing force in natural selection, and natural selection should favor individuals that possess forms of genes, or alleles, that make them more resistant to infection," said O'Donnell, a UW associate professor of psychology. "In some cases, an individual that has more than one form of a gene can ward off more parasites. In humans, for example, there are different forms of a blood gene that can help ward off malaria parasites. People with two different alleles for this gene are more resistant to malaria."

Because they are haploid, Hymenopteran males can't have alternate forms of any genes, or in other words, individual males have no genetic variability. This, O'Donnell and Beshers contend, puts males at
'"/>

Contact: Joel Schwarz
joels@u.washington.edu
206-543-2580
University of Washington
24-May-2004


Page: 1 2 3

Related biology news :

1. Gene clusters predict atherosclerosis severity, susceptibility
2. Study helps explain island populations susceptibility to exotic diseases
3. Protein may reduce susceptibility to autoimmune disease
4. Gene variants may increase susceptibility to type 2 diabetes
5. Gene differences may alter susceptibility to multiple sclerosis
6. Breast cancer susceptibility genes play role in DNA repair
7. Three genes linked to psoriasis susceptibility identified on chromosome 17
8. OHSU scientists uncover key protein for Fanconi anemia, cancer susceptibility
9. Gene that controls susceptibility to tuberculosis discovered
10. TSRI scientists show that rare genetic mutations increase susceptibility to sepsis
11. Alcohol abuse may increase susceptibility to HIV infection

Post Your Comments:
(Date:12/10/2014)... , December 9, 2014 ... BCARD Platform   ... meeting scheduling solutions for business-to-business (B2B) events, today ... leader in mobile near-field communication (NFC), Bluetooth low ...      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow will ...
(Date:12/3/2014)... , Dec. 2, 2014 As part of ... Inception Technologies is pleased to announce the release of ... customers to collect the workforce data that they need. ... have been left by existing readers. Many such devices ... connectivity and modern technology. Older models force users to ...
(Date:11/21/2014)... JOSE, Calif. , Nov. 20, 2014   ... global leader in microcontroller (MCU) and touch technology solutions, ... digital temperature sensors with the widest V cc ... delivers higher temperature accuracy and faster I 2 C ... registers and serial EEPROM memory making them ideal for ...
Breaking Biology News(10 mins):Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Inception Technologies to Release New Biometric Reader 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4
(Date:12/19/2014)... (PRWEB) December 18, 2014 LayerBio is ... ophthalmology and wound care. The National Eye Institute (NEI) ... LayerBio a Phase I SBIR grant to develop a ... are the most common cause of vision loss in ... blindness worldwide. According to Dr. Ken Mandell, LayerBio’s Founder ...
(Date:12/19/2014)... 2014 The empty capsules market ... ageing population and technological innovations in the empty ... are catalysing the growth of the empty capsules ... , Scope of Report , The report ... new entrants/smaller firms to gauge the pulse of ...
(Date:12/19/2014)... Dec. 18, 2014 Relmada Therapeutics, Inc. (OTCQB: ... treatment of chronic pain, announced the results of its ... "This was a transformational year in Relmada,s history and ... our company," said Sergio Traversa , chief executive ... executed on key financial, human resource and clinical development ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Ipsen ... IPN; ADR: IPSEY), today announced that ... to as Somatuline®) was approved by the U.S. ... of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult patients ... or metastatic disease to improve progression-free survival (PFS). ...
Breaking Biology Technology:LayerBio Awarded NIH Grant to Develop a Drug Delivery Device for Cataract Surgery 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8
Cached News: